Monitoring for retinal toxicity in patients taking hydroxychloroquine and chloroquine

Rheumatology - Tập 58 Số 1 - Trang 3-4 - 2019
Imran H. Yusuf1, Joanna Ledingham2, Elizabeth MacPhie3, Andrew Lotery4, James Galloway5
1Oxford Eye Hospital, John Radcliffe Hospital, Oxford, UK
2Department of Rheumatology, Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital, Portsmouth, UK
3Department of Rheumatology, Lancashire Care NHS Foundation Trust, Minerva Health Centre, Preston, UK
4Department of Ophthalmology, University of Southampton NHS Foundation Trust, Southampton, UK
5Department of Rheumatology, King’s College Hospital NHS Foundation Trust, London, UK

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ledingham, 2017, BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs, Rheumatology (Oxford), 56, 2257

Latasiewicz, 2017, Hydroxychloroquine retinopathy: an emerging problem, Eye, 31, 972

Yusuf, 2017, Hydroxychloroquine retinopathy, Eye, 31, 828

Royal College of Ophthalmologists (RCOphth), 2018

2018

Thông tin
Thông tin xuất bản

Rheumatology

Tập 58 Số 1

3-4

Thông tin tác giả